D. T. Max

420 total citations
7 papers, 298 citations indexed

About

D. T. Max is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, D. T. Max has authored 7 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 2 papers in Surgery and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in D. T. Max's work include Prostate Cancer Treatment and Research (3 papers), Hormonal and reproductive studies (2 papers) and Antibiotics Pharmacokinetics and Efficacy (1 paper). D. T. Max is often cited by papers focused on Prostate Cancer Treatment and Research (3 papers), Hormonal and reproductive studies (2 papers) and Antibiotics Pharmacokinetics and Efficacy (1 paper). D. T. Max collaborates with scholars based in United States and India. D. T. Max's co-authors include Richard J. Santen, Harold A. Harvey, L. Michael Glode, Barry S. Stein, Allan Lipton, Joseph P. Smith, L. M. Demers, Andrea Manni, Gerald P. Murphy and Joseph A. Smith and has published in prestigious journals such as Journal of Clinical Oncology, Endocrine Reviews and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

D. T. Max

7 papers receiving 263 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. T. Max United States 5 122 113 101 92 49 7 298
Wenlong Bai United States 4 36 0.3× 77 0.7× 43 0.4× 128 1.4× 55 1.1× 4 359
Martine Applanat France 3 60 0.5× 61 0.5× 14 0.1× 42 0.5× 56 1.1× 4 267
S.E. Bulun United States 5 73 0.6× 157 1.4× 11 0.1× 160 1.7× 53 1.1× 9 353
Shelley Hedwards Australia 5 50 0.4× 21 0.2× 83 0.8× 102 1.1× 30 0.6× 5 267
Jianfeng Zhang China 8 29 0.2× 33 0.3× 143 1.4× 63 0.7× 33 0.7× 13 327
Laura Hautala Finland 11 42 0.3× 75 0.7× 19 0.2× 52 0.6× 91 1.9× 19 411
Stephanie Beall United States 11 34 0.3× 183 1.6× 23 0.2× 53 0.6× 52 1.1× 15 460
S. Fournier France 10 248 2.0× 59 0.5× 18 0.2× 432 4.7× 238 4.9× 15 605
P. Vierikko Finland 11 39 0.3× 193 1.7× 10 0.1× 111 1.2× 21 0.4× 14 318
Marie Pickering Australia 5 40 0.3× 15 0.1× 73 0.7× 94 1.0× 62 1.3× 7 205

Countries citing papers authored by D. T. Max

Since Specialization
Citations

This map shows the geographic impact of D. T. Max's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. T. Max with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. T. Max more than expected).

Fields of papers citing papers by D. T. Max

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. T. Max. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. T. Max. The network helps show where D. T. Max may publish in the future.

Co-authorship network of co-authors of D. T. Max

This figure shows the co-authorship network connecting the top 25 collaborators of D. T. Max. A scholar is included among the top collaborators of D. T. Max based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. T. Max. D. T. Max is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Max, D. T., Jessica Flynn, Erin F. Gillespie, et al.. (2023). Locoregional Control Benefit of a Tumor Bed Boost for Ductal Carcinoma In Situ (DCIS). International Journal of Radiation Oncology*Biology*Physics. 117(2). e174–e174. 1 indexed citations
2.
Sennello, Lawrence T., Richard A. Finley, Sou-Yie Chu, et al.. (1986). Single-Dose Pharmacokinetics of Leuprolide in Humans Following Intravenous and Subcutaneous Administration. Journal of Pharmaceutical Sciences. 75(2). 158–160. 37 indexed citations
3.
Manni, Andrea, Richard J. Santen, Harold A. Harvey, Allan Lipton, & D. T. Max. (1986). Treatment of Breast Cancer with Gonadotropin-Releasing Hormone. Endocrine Reviews. 7(1). 89–94. 71 indexed citations
4.
Smith, Joseph A., L. Michael Glode, John N. Wettlaufer, et al.. (1985). Clinical effects of gonadotropin-releasing hormone analogue in metastatic carcinoma of prostate. Urology. 25(2). 106–114. 62 indexed citations
5.
Harvey, Harold A., et al.. (1985). Medical castration produced by the GnRH analogue leuprolide to treat metastatic breast cancer.. Journal of Clinical Oncology. 3(8). 1068–1072. 44 indexed citations
6.
Santen, Richard J., L. M. Demers, D. T. Max, et al.. (1984). Long Term Effects of Administration of a Gonadotropin Releasing Hormone Superagonist Analog in Men with Prostatic Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 58(2). 397–400. 82 indexed citations
7.
Warner, Barry A., Richard J. Santen, L. M. Demers, & D. T. Max. (1981). [D-LEU6DES-GLY-NH210, pro-ethylamide9]-gonadotropin releasing hormone (leuprolide): a 'medical castration' for the treatment of prostatic carcinoma. Clinical research. 29(3). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026